Clinical Trial Support
Serametrix Provides CLIA-Certified Laboratory Services and Clinical Trial Support for Clinical Investigations
Serametrix has a proven track record of developing de-novo assays and commercializing assays for large scale clinical trials. Our MDSC assay, which has evolved from an exploratory research biomarker to a CLIA clinical tool for patient selection, is proving highly successful.
All immunotherapy monitoring studies conducted at Serametrix in support of clinical trials are carried out to GLP standards and adhere to our quality control process. Our commitment to quality is evident in every assay and every project. From training, security, tracking, and redundancy your samples and data are safe with us.
Our services including biomarker development, specimen collection and logistics, multiple testing platforms, and laboratory manual documentation. Serametrix provides kits and requisition forms as desired for a study. With our expertise in immune oncology, partnership with leading academics in the industry, and locations on three continents, Serametrix is your ideal partner for immunotherapy clinical trial support.
To discuss ideas for your study or request a quote, click here.